Venture Strategy & Design
- Shape bold ideas into fundable, scalable ventures
- Define product-market fit, business models, and go-to-market strategies
- Support scientific founders with roadmaps, storytelling, and investor readiness
You lead the science. We build the company. Solutioneering steps in as a fractional COO or a fractional CXO to design the operational architecture that lets research-driven organisations grow intentionally.
Experience built alongside
Solutioneering provides fractional COO and executive leadership to science-driven and technically complex ventures. We work with biotech, biomedical, medical device, and research-founded companies navigating early growth, fundraising, regulatory milestones, and operational scale.
Our experience spans venture development, operational build-out, commercialisation strategy, and research translation. We operate inside regulated, research-intensive environments where technical nuance, capital constraints, and execution risk intersect.
Biotech and deep tech ventures are built on rigorous science and technical depth. We work comfortably inside those environments. We understand how research milestones, regulatory pathways, capital strategy, and operational systems must align.
Turning breakthrough science into a scalable company requires more than strong data. It requires structured execution.
From hiring plans to fundraising readiness, regulatory sequencing to commercialisation strategy, we build the infrastructure that supports scientific progress rather than slowing it down.
Solutioneering isn’t just a consulting firm — we listen to your needs and aspirations to help you engineer innovative and effective solutions. We’re your strategic partner in building what’s next.
We work inside regulated, research-intensive environments — the places where research milestones, regulatory pathways, and capital strategy have to line up.
Translational strategies connecting scientific IP to healthcare use cases.
Clinical value proposition, surgical workflow integration, and hospital adoption.
Non-invasive neuroimaging and diagnostic platforms moving toward clinical use.
Research-founded ventures navigating early growth, fundraising, and regulatory milestones.
Bridging scientific depth and operational execution across diagnostic platforms.
Mission-aligned commercialisation for impact-driven investors and collaborators.
Tell us what you’re building and where it feels stuck. We’ll come back with a considered view of how fractional leadership would help.